Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 16 di 16
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignancies 2023 D’Amore, FabioPavan, LauraPiazza, FrancescoPravato, StefanoScapinello, GretaVianello, FabrizioZambello, RenatoPadoan, AndreaTrentin, LivioVisentin, Andrea + FRONTIERS IN ONCOLOGY - -
Focal adhesion kinase activation by calcium-dependent calpain is involved in chronic lymphocytic leukaemia cell aggressiveness 2023 Severin F.Visentin A.Pagnin E.Trimarco V.Pravato S.Facco M.Trentin L.Frezzato F. + BRITISH JOURNAL OF HAEMATOLOGY - -
Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi 2023 Trentin, LivioVisentin, AndreaPravato, Stefano + HEMASPHERE - -
Anaemia during venetoclax ramp-up phase: Do not forget unusual causes 2022 Cavarretta, Chiara AdeleVisentin, AndreaPravato, StefanoPiazza, FrancescoBasso, DanielaTrentin, Livio + INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY - -
Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study 2022 Visentin, AndreaPravato, StefanoAngotzi, FrancescoCellini, AlessandroTrentin, Livio + FRONTIERS IN ONCOLOGY - -
A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency 2022 Visentin, AndreaPravato, StefanoCellini, AlessandroAngotzi, FrancescoCavarretta, Chiara AdeleRuocco, ValeriaPiazza, FrancescoTrentin, Livio + CURRENT ONCOLOGY - -
Continous Treatment with Ibrutinib in 100 Untreated Patients with TP53 Disrupted Chronic Lymphocytic Leukemia. A Real‐Life Campus CLL Study 2022 Visentin, AndreaPravato, StefanoPiazza, FrancescoTrentin, Livio + AMERICAN JOURNAL OF HEMATOLOGY - -
From Biology to Treatment of Monoclonal Gammopathies of Neurological Significance 2022 Visentin, AndreaPravato, StefanoCastellani, FrancescaCampagnolo, MartaAngotzi, FrancescoCavarretta, Chiara AdeleCellini, AlessandroRuocco, ValeriaSalvalaggio, AlessandroTrentin, LivioBriani, Chiara + CANCERS - -
Targeting of HSP70/HSF1 Axis Abrogates In Vitro Ibrutinib-Resistance in Chronic Lymphocytic Leukemia 2021 Frezzato, FedericaVisentin, AndreaSeverin, FilippoPizzo, SerenaRuggeri, EdoardoMouawad, NaylaMartinello, LeonardoPagnin, ElisaTrimarco, ValentinaTonini, AlessiaCarraro, SamuelaPravato, StefanoManni, SabrinaPiazza, FrancescoBrunati, Anna MariaFacco, MonicaTrentin, Livio + CANCERS - -
Ibrutinib in relapsed hairy cell leukemia variant: a case report and review of the literature 2020 Visentin, AndreaTrimarco, ValentinaPravato, StefanoGargarella, Leila RomanoFrezzato, FedericaScapinello, GretaFacco, MonicaSemenzato, GianpietroPiazza, FrancescoTrentin, Livio + HEMATOLOGICAL ONCOLOGY - -
Lights and Shade of Next-Generation Pi3k Inhibitors in Chronic Lymphocytic Leukemia 2020 Visentin, AndreaFrezzato, FedericaSeverin, FilippoPravato, StefanoRomano Gargarella, LeilaManni, SabrinaPizzo, SerenaFacco, MonicaBrunati, Anna MariaSemenzato, GianpietroPiazza, FrancescoTrentin, Livio + ONCOTARGETS AND THERAPY - -
The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia 2019 Visentin, AndreaRigolin, Gian MatteoFrezzato, FedericaScomazzon, EdoardoPravato, StefanoFacco, MonicaSemenzato, GianpietroTrentin, Livio + BRITISH JOURNAL OF CANCER - -
BCR kinase inhibitors, idelalisib and ibrutinib, are active and effective in Richter syndrome 2019 Visentin, AndreaImbergamo, SilviaSCOMAZZON, EDOARDOPRAVATO, STEFANOFrezzato, FedericaPizzi, MarcoVio, StefaniaGREGIANIN, MICHELEBurei, MartaFacco, MonicaSemenzato, GianpietroPiazza, FrancescoTrentin, Livio + BRITISH JOURNAL OF HAEMATOLOGY - -
Prognostic and Predictive Effect of IGHV Mutational Status and Load in Chronic Lymphocytic Leukemia: Focus on FCR and BR Treatments 2019 Visentin, AndreaFacco, MonicaGurrieri, CarmelaPagnin, ElisaMartini, VeronicaFrezzato, FedericaTrimarco, ValentinaSeverin, FilippoRaggi, FlaviaScomazzon, EdoardoPravato, StefanoPiazza, FrancescoSemenzato, GianpietroTrentin, Livio + CLINICAL LYMPHOMA MYELOMA & LEUKEMIA - -
Dabigatran in ibrutinib-treated patients with atrial fibrillation and lymphoproliferative diseases: Experience of 4 cases 2018 Visentin, AndreaCampello, ElenaScomazzon, EdoardoSpiezia, LucaPravato, StefanoPiazza, FrancescoSemenzato, GianpietroSimioni, PaoloTrentin, Livio + HEMATOLOGICAL ONCOLOGY - -
Enlarged Virchow Robin spaces associate with cognitive decline in multiple sclerosis 2017 Alice FavarettoAndrea LazzarottoRICCARDI, ALICEStefano PravatoMonica MargoniFrancesco CausinDario SeppiDavide PoggialiPaolo Gallo + PLOS ONE - -
Mostrati risultati da 1 a 16 di 16
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile